128 related articles for article (PubMed ID: 1599804)
1. Clinical trials of bestatin for leukemia and solid tumors.
Ota K; Uzuka Y
Biotherapy; 1992; 4(3):205-14. PubMed ID: 1599804
[TBL] [Abstract][Full Text] [Related]
2. Review of ubenimex (Bestatin): clinical research.
Ota K
Biomed Pharmacother; 1991; 45(2-3):55-60. PubMed ID: 1912370
[TBL] [Abstract][Full Text] [Related]
3. Randomized controlled study of chemoimmunotherapy with bestatin of acute nonlymphocytic leukemia in adults.
Ota K; Ogawa N
Biomed Pharmacother; 1990; 44(2):93-101. PubMed ID: 2224060
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy with bestatin for acute nonlymphocytic leukemia in adults.
Ota K; Kurita S; Yamada K; Masaoka T; Uzuka Y; Ogawa N
Cancer Immunol Immunother; 1986; 23(1):5-10. PubMed ID: 3533256
[TBL] [Abstract][Full Text] [Related]
5. [A new antitumor drug with immunomodulating activity, ubenimex (bestatin)].
Tsukagoshi S
Gan To Kagaku Ryoho; 1987 Jul; 14(7):2385-91. PubMed ID: 3496857
[TBL] [Abstract][Full Text] [Related]
6. [Results of follow-up studies on prognosis after immunotherapy with bestatin in acute nonlymphocytic leukemia].
Ota K; Kurita S; Yamada K; Masaoka T; Uzuka Y; Ogawa N
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1017-25. PubMed ID: 3963846
[TBL] [Abstract][Full Text] [Related]
7. The effect of bestatin on patients with acute and chronic leukemia and malignant lymphoma.
Arimori S; Nagao T; Shimizu Y; Watanabe K; Komatsuda M
Tokai J Exp Clin Med; 1980 Jan; 5(1):63-71. PubMed ID: 6930119
[TBL] [Abstract][Full Text] [Related]
8. Bestatin treatment of myelodysplastic syndromes and chronic myelogenous leukemia.
Usuka Y; Saito Y
Biomed Pharmacother; 1991; 45(2-3):87-93. PubMed ID: 1912373
[TBL] [Abstract][Full Text] [Related]
9. [Immunotherapy with bestatin for acute non-lymphocytic leukemia (ANLL) in adults].
Kurita S; Ota K; Yamada K; Massaoka T; Uzuka Y; Ogawa N
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2742-50. PubMed ID: 6508324
[TBL] [Abstract][Full Text] [Related]
10. Ubenimex in the treatment of acute nonlymphocytic leukemia in adults.
Urabe A; Mutoh Y; Mizoguchi H; Takaku F; Ogawa N
Ann Hematol; 1993 Aug; 67(2):63-6. PubMed ID: 8347731
[TBL] [Abstract][Full Text] [Related]
11. Long-term cytogenetic remission with ubenimex monotherapy in a case of chronic myeloid leukemia.
Kanamori H; Takasaki H; Takabayashi M; Yamaji S; Koharazawa H; Fujimaki K; Taguchi J; Ishigatsubo Y
Anticancer Drugs; 2004 Aug; 15(7):729-31. PubMed ID: 15269606
[TBL] [Abstract][Full Text] [Related]
12. [Bestatin therapy of chronic myelogenous leukemia].
Uzuka Y; Saito Y
Gan To Kagaku Ryoho; 1993 Feb; 20(2):207-14. PubMed ID: 8434958
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant bestatin (Ubenimex) treatment following full-dose local irradiation for bladder carcinoma.
Blomgren H; Esposti PL; Näslund I; Johansen L; Lemming O
Acta Oncol; 1990; 29(6):809-12. PubMed ID: 2223154
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant Bestatin immunotherapy in patients with transitional cell carcinoma of the bladder. Clinical results of a randomized trial.
Blomgren H; Näslund I; Esposti PL; Johansen L; Aaskoven O
Cancer Immunol Immunother; 1987; 25(1):41-6. PubMed ID: 3594491
[TBL] [Abstract][Full Text] [Related]
15. Effects of ubenimex, a biological response modifier, on myelodysplastic syndrome and chronic leukemia.
Tatsumi N; Sannomiya Y; Sasaki A; Im T; Ota K; Oohira H; Nakao H; Yasui Y
Biomed Pharmacother; 1991; 45(2-3):95-103. PubMed ID: 1912374
[TBL] [Abstract][Full Text] [Related]
16. Radioreductive effect of bestatin (Ubenimex) in BALB/c mice.
Horiuchi K; Miyamoto T
Int J Radiat Biol; 1992 Jul; 62(1):73-80. PubMed ID: 1353778
[TBL] [Abstract][Full Text] [Related]
17. [Phase III study of bestatin in patients with malignant skin tumors. (1) Malignant melanoma].
Ikeda S; Ishihara K; Taguchi G
Gan To Kagaku Ryoho; 1985 Jan; 12(1):77-85. PubMed ID: 3881086
[TBL] [Abstract][Full Text] [Related]
18. A review of clinical studies of bestatin.
Oka S
Recent Results Cancer Res; 1980; 75():126-32. PubMed ID: 7015425
[TBL] [Abstract][Full Text] [Related]
19. Randomized double-blind placebo-controlled trial of bestatin in patients with resected stage I squamous-cell lung carcinoma.
Ichinose Y; Genka K; Koike T; Kato H; Watanabe Y; Mori T; Iioka S; Sakuma A; Ohta M;
J Natl Cancer Inst; 2003 Apr; 95(8):605-10. PubMed ID: 12697853
[TBL] [Abstract][Full Text] [Related]
20. [Phase III controlled studies of bestatin in malignant tumors of the skin--results of treatment of squamous cell carcinoma and genital Paget's disease].
Ikeda S; Ishihara K; Taguchi G
Gan To Kagaku Ryoho; 1985 Jun; 12(6):1260-6. PubMed ID: 2988457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
